Hans Van Vlierberghe

ORCID: 0000-0003-0647-9238
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Organ Transplantation Techniques and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Liver physiology and pathology
  • Renal Transplantation Outcomes and Treatments
  • Liver Diseases and Immunity
  • Cancer, Hypoxia, and Metabolism
  • Drug-Induced Hepatotoxicity and Protection
  • Glycosylation and Glycoproteins Research
  • Cancer Immunotherapy and Biomarkers
  • Endoplasmic Reticulum Stress and Disease
  • Hemoglobinopathies and Related Disorders
  • Pancreatic and Hepatic Oncology Research
  • Alcohol Consumption and Health Effects
  • Iron Metabolism and Disorders
  • Systemic Lupus Erythematosus Research
  • Pancreatitis Pathology and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Transplantation: Methods and Outcomes
  • Neonatal Health and Biochemistry
  • Organ Donation and Transplantation

Ghent University Hospital
2016-2025

Ghent University
2014-2024

Universitair Ziekenhuis Brussel
2006-2021

ERN GUARD-Heart
2021

European Foundation for the Study of Chronic Liver Failure
2021

VIB-UGent Center for Medical Biotechnology
2017

Creative Research Enterprises (United States)
2016

Bio-Medical Science (South Korea)
2015

GTx (United States)
2014

Fund for Scientific Research
2013

The liver is the largest solid organ in body, yet it remains incompletely characterized. Here we present a spatial proteogenomic atlas of healthy and obese human murine combining single-cell CITE-seq, single-nuclei sequencing, transcriptomics, proteomics. By integrating these multi-omic datasets, provide validated strategies to reliably discriminate localize all hepatic cells, including population lipid-associated macrophages (LAMs) at bile ducts. We then align this across seven species,...

10.1016/j.cell.2021.12.018 article EN cc-by Cell 2022-01-01
Homie Razavi Imam Waked Christoph Sarrazin Robert P. Myers Ramazan İdilman and 90 more Filipe Calinas W. Vogel Maria Cássia Mendes Corrêa Christophe Hézode Pablo Lázaro Ulus Salih Akarca Soo Aleman İsmail Balık Thomas Berg Florian Bihl Marc Bilodeau Antonio Javier Blasco Carlos Eduardo Brandão‐Mello Philip Bruggmann Marı́a Buti José Luís Calleja Hugo Cheinquer Peer Brehm Christensen Mette Rye Clausen Henrique Sergio Coelho Matthew Cramp G.J. Dore W. Doss Ann‐Sofi Duberg Manal H. El‐Sayed Gül Ergör Gamal Esmat Karolin Falconer J Félix Maria Lúcia Gomes Ferraz Paulo Roberto Abrão Ferreira Soňa Fraňková Javier García‐Samaniego Jan Gerstoft José Gíria Fernando Lopes Gonçales E. Gower Michael Gschwantler Mário G. Pessôa S. J. Hindman Heribert Hofer Petr Husa Martin Kåberg Kelly Kaita Achim Kautz Sabahattin Kaymakoğlu Mel Krajden Henrik Krarup Wim Laleman Daniel Lavanchy Rui Tato Marinho Paul Marotta Stefan Mauss Christophe Moreno K. Murphy Francesco Negro Vratislav Němeček Necati Örmecı Anne Øvrehus Julie Parkes Ken Pasini Kevork Peltekian Alnoor Ramji Nathalia Rodrigues dos Reis S. Roberts William Rosenberg Françoise Roudot‐Thoraval Stephen Ryder Rui Sarmento‐Castro David Semela Morris Sherman Gamal Shiha William Sievert Jan Šperl Peter Stärkel R.E. Stauber A. Thompson Petr Urbánek Pierre Van Damme Ingo van Thiel Hans Van Vlierberghe Dominique Vandijck Heiner Wedemeyer Nina Weis Johannes Wiegand A. Yosry Amany Zekry Markus Cornberg Beat Müllhaupt Chris Estes

Summary The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population ages. A modelling approach was used estimate total number viremic infections, diagnosed, treated and new infections in 2013. In addition, model change progression mortality 2013–2030. Finally, expert panel consensus capture current treatment practices each country. Using today's paradigm, projected decline or remain flat all countries studied. However, same time period, individuals with...

10.1111/jvh.12248 article EN Journal of Viral Hepatitis 2014-04-08

Metabolic-associated fatty liver disease (MAFLD) represents a spectrum of states ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). Hepatic macrophages, specifically Kupffer cells (KCs), are suggested play important roles in the pathogenesis MAFLD through their activation, although exact played by these remain unclear. Here, we demonstrated that KCs were reduced being replaced macrophages originating bone marrow. Recruited existed two subsets with distinct activation...

10.1016/j.immuni.2020.08.004 article EN cc-by Immunity 2020-09-01
Jonel Trebicka Javier Fernández Mária Papp Paolo Caraceni Wim Laleman and 95 more Carmine Gambino Ilaria Giovo Frank Erhard Uschner César Jiménez Rajeshwar P. Mookerjee Thierry Gustot Agustı́n Albillos Rafael Bañares Martin Janíčko Christian J. Steib Thomas Reiberger Juan Acevedo Pietro Gatti William Bernal Stefan Zeuzem Alexander Zipprich Salvatore Piano Thomas Berg Tony Bruns Flemming Bendtsen Minneke J. Coenraad Manuela Merli Rudolf Stauber Heinz Zoller José Presa Ramos Cristina Solé Germán Soriano Andrea De Gottardi Henning Grønbæk Faouzi Saliba Christian Trautwein Osman Özdoğan Sven Francque Stephen Ryder Pierre Nahon Manuel Romero‐Gómez Hans Van Vlierberghe Claire Francoz Michael P. Manns Elisabet García Manuel Tufoni Àlex Amorós Marco Pavesi Cristina Sánchez Anna Curto Carla Pitarch Antonella Putignano Esau Moreno Debbie L. Shawcross Ferrán Aguilar J. J. Clariá Paola Ponzo Christian Jansen Zsuzsanna Vitális Giacomo Zaccherini Boglárka Balogh Vı́ctor Vargas Sara Montagnese Carlo Alessandria Mauro Bernardi Pere Ginés Rajiv Jalan Richard Moreau Paolo Angeli Vicente Arroyo Miriam Maschmeier David Semela Laure Elkrief Ahmed M. Elsharkawy Tamás Tornai István Tornai I Altorjay Agnese Antognoli Maurizio Baldassarre Martina Gagliardi Eleonora Bertoli Sara Mareso Alessandra Brocca Daniela Campion Giorgio Maria Saracco Martina Rizzo Jennifer Lehmann Alessandra Pohlmann Michael Praktiknjo Robert Schierwagen Elsa Solà Nesrine Amari Miguel Rodriguez Frederik Nevens Ana Clemente Peter Jarčuška Alexander L. Gerbes Mattias Mandorfer Christoph Welsch Emanuela Ciracì

•Patients with acutely decompensated cirrhosis without ACLF develop 3 different clinical courses.•Patients pre-ACLF within 90 days and have high systemic inflammation mortality.•Patients unstable suffer from complications of severe portal hypertension.•Patients stable less frequent lower 1-year mortality risk. Background & AimsAcute decompensation (AD) is defined as the acute development ascites, gastrointestinal hemorrhage, hepatic encephalopathy, infection or any combination thereof,...

10.1016/j.jhep.2020.06.013 article EN cc-by-nc-nd Journal of Hepatology 2020-07-13

10.1016/s0140-6736(23)01796-8 article EN The Lancet 2023-10-20
Jonel Trebicka Javier Fernández Mária Papp Paolo Caraceni Wim Laleman and 95 more Carmine Gambino Ilaria Giovo Frank Erhard Uschner Christian Jansen César Jiménez Rajeshwar P. Mookerjee Thierry Gustot Agustı́n Albillos Rafael Bañares Peter Jarčuška Christian J. Steib Thomas Reiberger Juan Acevedo Pietro Gatti Debbie L. Shawcross Stefan Zeuzem Alexander Zipprich Salvatore Piano Thomas Berg Tony Bruns Karen Vagner Danielsen Minneke J. Coenraad Manuela Merli Rudolf Stauber Heinz Zoller José Presa Ramos Cristina Solé Germán Soriano Andrea De Gottardi Henning Grønbæk Faouzi Saliba Christian Trautwein Haluk Tarık Kani Sven Francque Stephen Ryder Pierre Nahon Manuel Romero‐Gómez Hans Van Vlierberghe Claire Francoz Michael P. Manns Elisabet García Manuel Tufoni Àlex Amorós Marco Pavesi Cristina Sánchez Michael Praktiknjo Anna Curto Carla Pitarch Antonella Putignano Esau Moreno William Bernal Ferrán Aguilar J. J. Clariá Paola Ponzo Zsuzsanna Vitális Giacomo Zaccherini Boglárka Balogh Alexander L. Gerbes Vı́ctor Vargas Carlo Alessandria Mauro Bernardi Pere Ginés Richard Moreau Paolo Angeli Rajiv Jalan Vicente Arroyo Miriam Maschmeier David Semela Laure Elkrief Ahmed M. Elsharkawy Tamás Tornai István Tornai I Altorjay Agnese Antognoli Maurizio Baldassarre Martina Gagliardi Eleonora Bertoli Sara Mareso Alessandra Brocca Daniela Campion Giorgio Maria Saracco Martina Rizzo Jennifer Lehmann Alessandra Pohlmann Maximilian Joseph Brol Johannes Chang Robert Schierwagen Elsa Solà Nesrine Amari Miguel Ángel Morán Rodríguez Frederik Nevens Ana Clemente Martin Janíčko Daniel Markwardt Mattias Mandorfer

Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading both these AD phenotypes. The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients (No = 1,071; 202). Medical history, clinical data laboratory were collected at enrolment during 90-day...

10.1016/j.jhep.2020.11.019 article EN cc-by-nc-nd Journal of Hepatology 2020-11-20

Knowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly terms of severity the disease. The aim this study was to describe demographic, baseline clinical characteristics and early outcomes a European cohort with SARS-CoV-2 infection.We conducted an international prospective across Europe confirmed by microbiological assay during first outbreak COVID-19 pandemic. Baseline characteristics, presentation,...

10.1136/gutjnl-2020-321923 article EN Gut 2020-06-22

Background Transarterial chemoembolization (TACE) is the recommended treatment for intermediate hepatocellular carcinoma (HCC) according to Barcelona Clinic Liver Cancer guidelines. Prospective uncontrolled studies suggest that yttrium 90 (90Y) transarterial radioembolization (TARE) a safe and effective alternative. Purpose To compare efficacy safety of TARE with TACE unresectable HCC. Materials Methods In this single-center prospective randomized controlled trial (TRACE), 90Y glass was...

10.1148/radiol.211806 article EN Radiology 2022-03-08

Graft hyperperfusion in small-for-size grafts (SFSG) is considered the main causal factor of syndrome (SFSS). We compared SFSG with a graft-to-recipient body ratio < or =0.8, and without graft inflow modulation (GIM) by means hemi-portocaval shunt (HPCS). Thirteen patients underwent adult-to-adult living donor liver transplantation (AALDLT): G1, n = 5 [4 right livers (RL) 1 left (LL)] GIM, G2, 8 (4 RL 4 LL) GIM. In G2 patients, portal vein flow (PVF) was significantly reduced HPCS: 190 +/-...

10.1111/j.1600-6143.2005.00850.x article EN cc-by-nc-nd American Journal of Transplantation 2005-05-12

To evaluate the clinical significance of modulating recipient portal inflow (rPVF) through perioperative ligation splenic artery in adult living-donor liver transplantation (ALDLTx) by focusing on vascular complications, intractable ascites production, and prevention small-for-size syndrome (SFSS).In ALDLTx, graft flow is enhanced to at least twice donor value, raising total inflow. Recipient hepatic arterial (rHAF) lower than expected. Portal hyperperfusion small grafts larger recipients...

10.1097/01.sla.0000055277.78876.b7 article EN Annals of Surgery 2003-03-01

CT and MR Imaging Findings in Focal Nodular Hyperplasia of the LiverRadiologic—Pathologic CorrelationK. J. Mortelé1, M. Praet2, H. Van Vlierberghe3, Kunnen1 P. R. Ros4Audio Available | Share

10.2214/ajr.175.3.1750687 article EN American Journal of Roentgenology 2000-09-01
Coming Soon ...